{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:11:17Z","timestamp":1790687477971,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T00:00:00Z","timestamp":1492732800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s11914-017-0360-5","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T06:08:34Z","timestamp":1492754914000},"page":"162-170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells"],"prefix":"10.1007","volume":"15","author":[{"given":"Luna","family":"Soley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyne","family":"Falank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela R.","family":"Reagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,21]]},"reference":[{"key":"360_CR1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fendo.2016.00067","volume":"7","author":"C Falank","year":"2016","unstructured":"Falank C, Fairfield H, Reagan MR. Signaling interplay between bone marrow adipose tissue and multiple myeloma cells. Front Endocrinol (Lausanne). 2016;7:67.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"360_CR2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrclinonc.2016.122","volume":"14","author":"S Manier","year":"2016","unstructured":"\u2022 Manier S, Salem KZ, Park J, Landau DA, Getz G, Ghobrial IM. Genomic complexity of multiple myeloma and its clinical implications. Nat Rev Clin Oncol. 2016;14:100\u201313. Provides an exhaustive summary of dysregulated miRNAs in myeloma","journal-title":"Nat Rev Clin Oncol"},{"key":"360_CR3","doi-asserted-by":"crossref","unstructured":"Yu W, Cao D-D, Li Q, et al. Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy. Oncotarget 2016;7(52):86075\u201386086.","DOI":"10.18632\/oncotarget.13342"},{"key":"360_CR4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/1471-2164-9-340","volume":"9","author":"M Scheideler","year":"2008","unstructured":"Scheideler M, Elabd C, Zaragosi L-E, et al. Comparative transcriptomics of human multipotent stem cells during adipogenesis and osteoblastogenesis. BMC Genomics. 2008;9:340.","journal-title":"BMC Genomics"},{"key":"360_CR5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.leu.2404658","volume":"21","author":"J Caers","year":"2007","unstructured":"Caers J, Deleu S, Belaid Z, et al. Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Leukemia. 2007;21:1580\u20134.","journal-title":"Leukemia"},{"key":"360_CR6","doi-asserted-by":"crossref","first-page":"60698","DOI":"10.18632\/oncotarget.10849","volume":"7","author":"L Di Marzo","year":"2016","unstructured":"Di Marzo L, Desantis V, Solimando AG, et al. Microenvironment drug resistance in multiple myeloma: emerging new players. Oncotarget. 2016;7:60698\u2013711.","journal-title":"Oncotarget"},{"key":"360_CR7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/1574888X09666140213203309","volume":"9","author":"J Chen","year":"2014","unstructured":"Chen J, Deng S, Zhang S, et al. The role of miRNAs in the differentiation of adipose-derived stem cells. Curr Stem Cell Res Ther. 2014;9:268\u201379.","journal-title":"Curr Stem Cell Res Ther"},{"key":"360_CR8","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1158\/1078-0432.CCR-14-1437","volume":"21","author":"Y Yang","year":"2015","unstructured":"Yang Y, Li F, Saha MN, Abdi J, Qiu L, Chang H. miR-137 and miR-197 induce apoptosis and suppress tumorigenicity by targeting MCL-1 in multiple myeloma. Clin Cancer Res. 2015;21:2399\u2013411.","journal-title":"Clin Cancer Res"},{"key":"360_CR9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4252\/wjsc.v5.i4.136","volume":"5","author":"M Fakhry","year":"2013","unstructured":"Fakhry M, Hamade E, Badran B, Buchet R, Magne D. Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. World J Stem Cells. 2013;5:136\u201348.","journal-title":"World J Stem Cells"},{"key":"360_CR10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd3179","volume":"9","author":"R Garzon","year":"2010","unstructured":"Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010;9:775\u201389.","journal-title":"Nat Rev Drug Discov"},{"key":"360_CR11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ. Oncomirs\u2014microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259\u201369.","journal-title":"Nat Rev Cancer"},{"key":"360_CR12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10238-015-0355-4","volume":"16","author":"X Shen","year":"2016","unstructured":"Shen X, Guo Y, Yu J, et al. miRNA-202 in bone marrow stromal cells affects the growth and adhesion of multiple myeloma cells by regulating B cell-activating factor. Clin Exp Med. 2016;16:307\u201316.","journal-title":"Clin Exp Med"},{"key":"360_CR13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.18632\/oncotarget.868","volume":"4","author":"HK Lee","year":"2013","unstructured":"Lee HK, Finniss S, Cazacu S, et al. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget. 2013;4:346\u201361.","journal-title":"Oncotarget"},{"key":"360_CR14","doi-asserted-by":"crossref","unstructured":"Dimopoulos K, Gimsing P, Gr\u00f8nbaek K. Aberrant microRNA expression in multiple myeloma. Eur J Haematol. 2013;91(2):95\u2013105.","DOI":"10.1111\/ejh.12124"},{"key":"360_CR15","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstr\u00f6m K, Bossios A, Sj\u00f6strand M, Lee JJ, L\u00f6tvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654\u20139.","journal-title":"Nat Cell Biol"},{"key":"360_CR16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2174\/156800912802429274","volume":"12","author":"M Lionetti","year":"2012","unstructured":"Lionetti M, Agnelli L, Lombardi L, Tassone P, Neri A. MicroRNAs in the pathobiology of multiple myeloma. Curr Cancer Drug Targets. 2012;12:823\u201337.","journal-title":"Curr Cancer Drug Targets"},{"key":"360_CR17","first-page":"334","volume":"3","author":"M Rossi","year":"2015","unstructured":"Rossi M, Tagliaferri P, Tassone P. MicroRNAs in multiple myeloma and related bone disease. Ann Transl Med. 2015;3:334.","journal-title":"Ann Transl Med"},{"key":"360_CR18","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2174\/156800912802429355","volume":"12","author":"P Tagliaferri","year":"2012","unstructured":"Tagliaferri P, Rossi M, Di Martino MT, et al. Promises and challenges of MicroRNA-based treatment of multiple myeloma. Curr Cancer Drug Targets. 2012;12:838\u201346.","journal-title":"Curr Cancer Drug Targets"},{"key":"360_CR19","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1182\/blood-2009-01-198408","volume":"113","author":"AM Roccaro","year":"2009","unstructured":"Roccaro AM, Sacco A, Thompson B, et al. MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. Blood. 2009;113:6669\u201380.","journal-title":"Blood"},{"key":"360_CR20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrendo.2015.25","volume":"11","author":"P Arner","year":"2015","unstructured":"Arner P, Kulyt\u00e9 A. MicroRNA regulatory networks in human adipose tissue and obesity. Nat Rev Endocrinol. 2015;11:276\u201388.","journal-title":"Nat Rev Endocrinol"},{"key":"360_CR21","doi-asserted-by":"crossref","first-page":"e80041","DOI":"10.1371\/journal.pone.0080041","volume":"8","author":"J Ma","year":"2013","unstructured":"Ma J, Jiang Z, He S, et al. Intrinsic features in microRNA transcriptomes link porcine visceral rather than subcutaneous adipose tissues to metabolic risk. PLoS One. 2013;8:e80041.","journal-title":"PLoS One"},{"key":"360_CR22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12032-014-0094-5","volume":"31","author":"J Ma","year":"2014","unstructured":"Ma J, Liu S, Wang Y. MicroRNA-21 and multiple myeloma: small molecule and big function. Med Oncol. 2014;31:94.","journal-title":"Med Oncol"},{"key":"360_CR23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13287-015-0116-z","volume":"6","author":"SR Baglio","year":"2015","unstructured":"\u2022 Baglio SR, Rooijers K, Koppers-Lalic D, et al. Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther. 2015;6:127. Provides compelling evidence for this review\u2019s interest in exosomal transfer of miRNAs as a potential means of microenvironment contribution to myeloma progression by elucidating the mechanisms by which exosomes originating from bone marrow mesenchymal stromal cells can facilitate tumor-stroma cross-talk","journal-title":"Stem Cell Res Ther"},{"key":"360_CR24","doi-asserted-by":"crossref","first-page":"39165","DOI":"10.18632\/oncotarget.5381","volume":"6","author":"A Seckinger","year":"2015","unstructured":"Seckinger A, Mei\u00dfner T, Moreaux J, et al. miRNAs in multiple myeloma\u2014a survival relevant complex regulator of gene expression. Oncotarget. 2015;6:39165\u201383.","journal-title":"Oncotarget"},{"key":"360_CR25","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/abbs\/gmu089","volume":"46","author":"H Xu","year":"2014","unstructured":"Xu H, Liu C, Zhang Y, et al. Let-7b-5p regulates proliferation and apoptosis in multiple myeloma by targeting IGF1R. Acta Biochim Biophys Sin Shanghai. 2014;46:965\u201372.","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"key":"360_CR26","doi-asserted-by":"crossref","unstructured":"Glavey S, Manier S, Sacco A, Rossi G, Ghobrial IM, Roccaro AM. The role of miRNAs in plasma cell dyscrasias. 2013;2:165\u2013173.","DOI":"10.2174\/2211536602666131126002144"},{"key":"360_CR27","doi-asserted-by":"crossref","first-page":"e110973","DOI":"10.1371\/journal.pone.0110973","volume":"9","author":"W Zhang","year":"2014","unstructured":"Zhang W, Wang YE, Zhang Y, et al. Global epigenetic regulation of microRNAs in multiple myeloma. PLoS One. 2014;9:e110973.","journal-title":"PLoS One"},{"key":"360_CR28","doi-asserted-by":"crossref","first-page":"19132","DOI":"10.18632\/oncotarget.4302","volume":"6","author":"MT Di Martino","year":"2015","unstructured":"Di Martino MT, Guzzi PH, Caracciolo D, et al. Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma. Oncotarget. 2015;6:19132\u201347.","journal-title":"Oncotarget"},{"key":"360_CR29","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/jcp.24669","volume":"229","author":"M Leotta","year":"2014","unstructured":"Leotta M, Biamonte L, Raimondi L, et al. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells. J Cell Physiol. 2014;229:2106\u201316.","journal-title":"J Cell Physiol"},{"key":"360_CR30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fendo.2016.00090","volume":"7","author":"EV Morris","year":"2016","unstructured":"\u2022 Morris EV, Edwards CM. Bone marrow adipose tissue: a new player in cancer metastasis to bone. Front Endocrinol (Lausanne). 2016;7:90. Discusses bone marrow adipose tissue in the context of the bone marrow microenvironment with particular attention to potential contributions to myeloma progression","journal-title":"Front Endocrinol (Lausanne)"},{"key":"360_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-016-0162-2","author":"MM McDonald","year":"2016","unstructured":"\u2022 McDonald MM, Fairfield H, Falank C, Reagan MR. Adipose, bone, and myeloma: contributions from the microenvironment. Calcif Tissue Int. 2016; doi: 10.1007\/s00223-016-0162-2 . Discuss bone marrow adipose tissue in the context of the bone marrow microenvironment with particular attention to potential contributions to myeloma progression","journal-title":"Calcif Tissue Int"},{"key":"360_CR32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2213-8587(14)70007-5","volume":"3","author":"MJ Devlin","year":"2015","unstructured":"Devlin MJ, Rosen CJ. The bone-fat interface: basic and clinical implications of marrow adiposity. Lancet Diabetes Endocrinol. 2015;3:141\u20137.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"360_CR33","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1182\/blood-2011-01-330407","volume":"118","author":"JA Fowler","year":"2011","unstructured":"Fowler JA, Lwin ST, Drake MT, et al. Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease. Blood. 2011;118:5872\u201382.","journal-title":"Blood"},{"key":"360_CR34","doi-asserted-by":"crossref","unstructured":"\u2022 Reagan MR, Ghobrial IM. Multiple myeloma-mesenchymal stem cells: characterization, origin, and tumor-promoting effects. Clin Cancer Res 2012;18:342\u2013349. Characterizes the ability of exosomes to mediate the exchange of genetic material, specifically miRNAs, between cells.","DOI":"10.1158\/1078-0432.CCR-11-2212"},{"key":"360_CR35","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI66517","volume":"123","author":"AM Roccaro","year":"2013","unstructured":"Roccaro AM, Sacco A, Maiso P, et al. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest. 2013;123:1542\u201355.","journal-title":"J Clin Invest"},{"key":"360_CR36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","volume":"110","author":"DD Taylor","year":"2008","unstructured":"Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110:13\u201321.","journal-title":"Gynecol Oncol"},{"key":"360_CR37","doi-asserted-by":"crossref","first-page":"30357","DOI":"10.18632\/oncotarget.4851","volume":"6","author":"A \u00d8verbye","year":"2015","unstructured":"\u00d8verbye A, Skotland T, Koehler CJ, et al. Identification of prostate cancer biomarkers in urinary exosomes. Oncotarget. 2015;6:30357\u201376.","journal-title":"Oncotarget"},{"key":"360_CR38","doi-asserted-by":"crossref","first-page":"e60014","DOI":"10.1371\/journal.pone.0060014","volume":"8","author":"AJ Trindade","year":"2013","unstructured":"Trindade AJ, Medvetz DA, Neuman NA, et al. MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM). PLoS One. 2013;8:e60014.","journal-title":"PLoS One"},{"key":"360_CR39","doi-asserted-by":"crossref","first-page":"27343","DOI":"10.18632\/oncotarget.4398","volume":"6","author":"MR Pitari","year":"2015","unstructured":"Pitari MR, Rossi M, Amodio N, et al. Inhibition of miR-21 restores RANKL\/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. Oncotarget. 2015;6:27343\u201358.","journal-title":"Oncotarget"},{"key":"360_CR40","doi-asserted-by":"crossref","first-page":"e58796","DOI":"10.1371\/journal.pone.0058796","volume":"8","author":"T Eguchi","year":"2013","unstructured":"Eguchi T, Watanabe K, Hara ES, Ono M, Kuboki T, Calderwood SK. OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells. PLoS One. 2013;8:e58796.","journal-title":"PLoS One"},{"key":"360_CR41","doi-asserted-by":"crossref","first-page":"38270","DOI":"10.18632\/oncotarget.5681","volume":"6","author":"F Li","year":"2015","unstructured":"Li F, Xu Y, Deng S, et al. MicroRNA-15a\/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma. Oncotarget. 2015;6:38270\u201382.","journal-title":"Oncotarget"},{"key":"360_CR42","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1182\/blood-2014-02-558007","volume":"124","author":"MR Reagan","year":"2014","unstructured":"Reagan MR, Mishima Y, Glavey SV, et al. Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model. Blood. 2014;124:3250\u20139.","journal-title":"Blood"},{"key":"360_CR43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fendo.2016.00085","volume":"7","author":"P Hardouin","year":"2016","unstructured":"Hardouin P, Rharass T, Lucas S. Bone marrow adipose tissue: to be or not to be a typical adipose tissue? Front Endocrinol (Lausanne). 2016;7:85.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"360_CR44","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1007\/s13277-015-3600-2","volume":"36","author":"J Peng","year":"2015","unstructured":"Peng J, Thakur A, Zhang S, et al. Expressions of miR-181a and miR-20a in RPMI8226 cell line and their potential as biomarkers for multiple myeloma. Tumor Biol. 2015;36:8545\u201352.","journal-title":"Tumor Biol"},{"key":"360_CR45","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/bjc.2012.525","volume":"107","author":"CI Jones","year":"2012","unstructured":"Jones CI, Zabolotskaya MV, King AJ, et al. Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma. Br J Cancer. 2012;107:1987\u201396.","journal-title":"Br J Cancer"},{"key":"360_CR46","doi-asserted-by":"crossref","unstructured":"Kl\u00f6ting N, Berthold S, Kovacs P, et al. MicroRNA Expression in Human Omental and Subcutaneous Adipose Tissue Polidori C (ed.). PLoS One. 2009;4(3):e4699.","DOI":"10.1371\/journal.pone.0004699"},{"key":"360_CR47","first-page":"6504593","volume":"2016","author":"L Raimondi","year":"2016","unstructured":"Raimondi L, De Luca A, Morelli E, et al. MicroRNAs: novel crossroads between myeloma cells and the bone marrow microenvironment. Biomed Res Int. 2016;2016:6504593.","journal-title":"Biomed Res Int"},{"key":"360_CR48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12860-015-0057-5","volume":"16","author":"PJ Martin","year":"2015","unstructured":"Martin PJ, Haren N, Ghali O, et al. Adipogenic RNAs are transferred in osteoblasts via bone marrow adipocytes-derived extracellular vesicles (EVs). BMC Cell Biol. 2015;16:10.","journal-title":"BMC Cell Biol"},{"key":"360_CR49","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.18632\/oncotarget.1202","volume":"4","author":"H Siemens","year":"2013","unstructured":"Siemens H, Jackstadt R, Kaller M, Hermeking H. Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Oncotarget. 2013;4:1399\u2013415.","journal-title":"Oncotarget"},{"key":"360_CR50","doi-asserted-by":"crossref","first-page":"26508","DOI":"10.18632\/oncotarget.4769","volume":"6","author":"C Bi","year":"2015","unstructured":"Bi C, Chung T-H, Huang G, et al. Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma. Oncotarget. 2015;6:26508\u201318.","journal-title":"Oncotarget"},{"key":"360_CR51","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3324\/haematol.2013.093500","volume":"99","author":"L Kubiczkova","year":"2014","unstructured":"Kubiczkova L, Kryukov F, Slaby O, et al. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance. Haematologica. 2014;99:511\u20138.","journal-title":"Haematologica"},{"key":"360_CR52","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.tips.2015.04.006","volume":"36","author":"JY Krzeszinski","year":"2015","unstructured":"Krzeszinski JY, Wan Y. New therapeutic targets for cancer bone metastasis. Trends Pharmacol Sci. 2015;36:360\u201373.","journal-title":"Trends Pharmacol Sci"},{"key":"360_CR53","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/stem.1615","volume":"32","author":"L Chen","year":"2014","unstructured":"Chen L, Holmstr\u00d8m K, Qiu W, et al. MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells. Stem Cells. 2014;32:902\u201312.","journal-title":"Stem Cells"},{"key":"360_CR54","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/oby.21561","volume":"24","author":"CA Lavery","year":"2016","unstructured":"Lavery CA, Kurowska-Stolarska M, Holmes WM, et al. miR-34a(-\/-) mice are susceptible to diet-induced obesity. Obesity. 2016;24:1741\u201351.","journal-title":"Obesity"},{"key":"360_CR55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.diff.2015.10.010","volume":"90","author":"H Park","year":"2015","unstructured":"Park H, Park H, Pak H-J, et al. miR-34a inhibits differentiation of human adipose tissue-derived stem cells by regulating cell cycle and senescence induction. Differentiation. 2015;90:91\u2013100.","journal-title":"Differentiation"},{"key":"360_CR56","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1128\/MCB.00596-14","volume":"34","author":"T Fu","year":"2014","unstructured":"Fu T, Seok S, Choi S, et al. MicroRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function. Mol Cell Biol. 2014;34:4130\u201342.","journal-title":"Mol Cell Biol"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-017-0360-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-017-0360-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-017-0360-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T01:11:03Z","timestamp":1601946663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-017-0360-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,21]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1007\/s11914-017-0360-5","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,21]]}}}